Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI

Yasushi Ueki1, Tatsuhiko Otsuka1, Sarah Bär1

  • 1Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Abstract

Insights

Different definitions for periprocedural myocardial infarction (MI) impact patient outcomes. The Academic Research Consortium-2 (ARC-2) and Society for Cardiovascular Angiography and Interventions (SCAI) criteria are more prognostic for cardiac death than older Universal Definition of Myocardial Infarction (UDMI) criteria.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomarker Research

Background:

  • Definitions for periprocedural myocardial infarction (MI) vary in biomarker thresholds and ischemia criteria, lacking robust validation.
  • This variability complicates accurate assessment of MI frequency and its clinical impact.

Purpose of the Study:

  • To evaluate the incidence and prognostic significance of periprocedural MI using different definitions in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI).

Main Methods:

  • Utilized data from the Bern PCI registry (2010-2018) for 4,404 patients with CCS undergoing PCI.
  • Assessed periprocedural MI using the third and fourth Universal Definition of Myocardial Infarction (UDMI), Academic Research Consortium-2 (ARC-2), and Society for Cardiovascular Angiography and Interventions (SCAI) criteria.
  • Primary endpoint was 1-year cardiac death.

Main Results:

  • Periprocedural MI rates varied: 18.0% (3rd UDMI), 14.9% (4th UDMI), 2.0% (ARC-2), and 2.0% (SCAI).
  • One-year cardiac mortality was 2.9% (3rd UDMI), 3.0% (4th UDMI), 5.8% (ARC-2), and 10.0% (SCAI).
  • ARC-2 and SCAI criteria demonstrated greater prognostic relevance for 1-year cardiac death compared to UDMI criteria.

Conclusions:

  • ARC-2 and SCAI criteria identified periprocedural MI less frequently (7-9 times) than UDMI criteria in CCS patients undergoing PCI.
  • Periprocedural MI identified by ARC-2 and SCAI criteria showed stronger prognostic value for 1-year cardiac death.
  • The findings highlight the importance of using validated, contemporary MI definitions for accurate risk stratification.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
44
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
53
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
227
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
226
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
67